Interleukin-1 activates a novel protein kinase that phosphorylates the epidermal-growth-factor receptor peptide T669

M Kracht1, M Shiroo, C J Marshall

  • 1Department of Development and Signalling, Babraham Institute, Cambridge, UK.

The Biochemical Journal
|September 15, 1994
PubMed

Insights

Researchers discovered a novel protein kinase in interleukin-1 (IL-1) stimulated cells that phosphorylates the epidermal growth factor (EGF) receptor. This enzyme may play a key role in IL-1 induced signaling pathways.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Biochemistry

Background:

  • Interleukin-1 (IL-1) is a key cytokine involved in inflammatory and immune responses.
  • The epidermal growth factor (EGF) receptor is a critical regulator of cell growth and differentiation.
  • Protein kinases play crucial roles in cellular signaling pathways, including those activated by IL-1 and EGF.

Purpose of the Study:

  • To isolate and characterize a novel protein kinase induced by IL-1 stimulation.
  • To investigate the substrate specificity and potential role of this kinase in cellular signaling.
  • To determine if this kinase is involved in the phosphorylation of the EGF receptor.

Main Methods:

  • Purification of the protein kinase from IL-1 stimulated KB cell cytosolic extracts using sequential chromatography.
  • Enzyme activity assays using a T669 peptide substrate, mimicking a site on the EGF receptor.
  • Comparison of the novel kinase with mitogen-activated protein (MAP) kinase using various substrates and antibodies.

Main Results:

  • A 45 kDa protein kinase was purified, which specifically phosphorylates the T669 peptide.
  • The purified kinase showed significantly lower activity on common MAP kinase substrates compared to p42 MAP kinase.
  • The enzyme's activity was regulated by phosphatases, suggesting a potential role for dual phosphorylation.

Conclusions:

  • A novel IL-1-induced protein kinase distinct from MAP kinase has been identified.
  • This kinase is a potential candidate for phosphorylating T669 of the EGF receptor.
  • The enzyme may represent a new component in IL-1-mediated kinase signaling cascades.

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...